The 2019 IPO market has been red-hot, and a lot of stellar new companies have missed out on the headline buzz they deserve. In this episode of Industry Focus: Healthcare, host Shannon Jones and Fool.com contributor Brian Feroldi dig into two under-the-radar medtech IPOs that have some serious long-term potential: organ transport company TransMedics (NASDAQ: TMDX) and stroke surgery innovator Silk Road Medical (NASDAQ: SILK). Tune in to learn what each of these companies offers to their patients, how the businesses work, the biggest risks and trends to watch, their potential addressable markets, which one looks like the better buy today, and more.
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. To get started investing, check out our quick-start guide to investing in stocks. A full transcript follows the video.